Arruda C G, Aldrighi J M, Bortolotto L A, Alecrin I N, Ramires J A F
Women's Health Clinic, Public Health School and Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brazil.
Gynecol Endocrinol. 2006 Oct;22(10):557-63. doi: 10.1080/09513590601005342.
Arterial hypertension and postmenopausal reduction of estrogen levels may be involved in modifications of the stiffness of large arteries.
To evaluate the pulse-wave velocity (PWV) and indirectly the arterial stiffness in hypertensive postmenopausal women submitted to hormone therapy with estradiol alone or combined with norethisterone acetate.
Forty-five hypertensive postmenopausal women were double-blindly, randomly assigned to three arms of treatment: placebo (group I); estradiol 2 mg/day (group II); or estradiol 2 mg/day and norethisterone acetate 1 mg/day (group III).
Arterial stiffness was assessed from PWV measurements of the common carotid and femoral arteries (CF-PWV) and the common carotid and radial arteries (CR-PWV) obtained using the automatic Complior(R) device, taken at baseline and after 12 weeks of treatment.
After the 12-week treatment, values of CF-PWV and CR-PWV were not significantly different (p = 0.910 and p = 0.736, respectively) among the groups. Systolic blood pressure showed a positive correlation with CF-PWV in groups II and III (p = 0.02 and p < 0.001, respectively).
PWV and arterial stiffness in postmenopausal hypertensive women did not reduce over a 12-week treatment with estradiol alone compared with the same period of treatment with estradiol combined with norethisterone acetate.
动脉高血压和绝经后雌激素水平降低可能与大动脉僵硬度的改变有关。
评估单独接受雌二醇或联合醋酸炔诺酮激素治疗的绝经后高血压女性的脉搏波速度(PWV),并间接评估其动脉僵硬度。
45名绝经后高血压女性被双盲、随机分配到三个治疗组:安慰剂组(I组);雌二醇2毫克/天组(II组);或雌二醇2毫克/天联合醋酸炔诺酮1毫克/天组(III组)。
使用自动Complior®设备在基线和治疗12周后测量颈总动脉和股动脉(CF-PWV)以及颈总动脉和桡动脉(CR-PWV)的PWV,以此评估动脉僵硬度。
治疗12周后,各组间CF-PWV和CR-PWV值无显著差异(分别为p = 0.910和p = 0.736)。II组和III组的收缩压与CF-PWV呈正相关(分别为p = 0.02和p < 0.001)。
与雌二醇联合醋酸炔诺酮治疗的同期相比,绝经后高血压女性单独使用雌二醇治疗12周后,PWV和动脉僵硬度并未降低。